Cork, Ireland, 13 May, 2008
Alimentary Health Ltd. (Alimentary Health),today announces that the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA), has granted orphan-drug designation to Bifidobacterium infantis 35624 for the treatment of pediatric ulcerative colitis (UC).
